Monoaminergic and histaminergic strategies and treatments in brain diseases

Monoaminergic and histaminergic strategies and treatments in brain diseases

The monoaminergic systems are the target of several drugs for the treatment of mood, motor and cognitive disorders as well as neurological conditions. In most cases, advances have occurred through serendipity, except for Parkinson’s disease where the pathophysiology led almost immediately to the int...

Full description

Bibliographic Details
Main Authors: Giuseppe Di Giovanni, Dubravka Svob Strac, Montse Sole, Mercedes Unzeta, Keith Francis Tipton, Dorotea Mück-Šeler, Irène Bolea, Laura Della Corte, Matea Nikolac Perkovic, Nela Pivac, Ilse Julia Smolders, Anna Stasiak, Wieslawa Agnieszka Fogel, Philippe De Deurwaerdère
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-11-01
Series:Frontiers in Neuroscience
Subjects:
Monoamine Oxidase Inhibitors
Neurodegenerative Diseases
Stroke
antidepressant
Drug Addition
antiparkinsonian treatments
Online Access:http://journal.frontiersin.org/Journal/10.3389/fnins.2016.00541/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fnins.2016.00541/full

Similar Items